vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Eton Pharmaceuticals, Inc. (ETON). Click either name above to swap in a different company.

Eton Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($21.3M vs $19.2M, roughly 1.1× CuriosityStream Inc.). Eton Pharmaceuticals, Inc. runs the higher net margin — 7.0% vs -19.7%, a 26.7% gap on every dollar of revenue. On growth, Eton Pharmaceuticals, Inc. posted the faster year-over-year revenue change (82.7% vs 35.8%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-11.6M). Over the past eight quarters, Eton Pharmaceuticals, Inc.'s revenue compounded faster (63.4% CAGR vs 26.5%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Eton Pharmaceuticals, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative therapies for rare diseases, pediatric care and hospital care segments. It mainly operates in the U.S. market, partnering with medical stakeholders to deliver accessible high-quality treatments to underserved patients.

CURI vs ETON — Head-to-Head

Bigger by revenue
ETON
ETON
1.1× larger
ETON
$21.3M
$19.2M
CURI
Growing faster (revenue YoY)
ETON
ETON
+46.9% gap
ETON
82.7%
35.8%
CURI
Higher net margin
ETON
ETON
26.7% more per $
ETON
7.0%
-19.7%
CURI
More free cash flow
CURI
CURI
$15.5M more FCF
CURI
$3.9M
$-11.6M
ETON
Faster 2-yr revenue CAGR
ETON
ETON
Annualised
ETON
63.4%
26.5%
CURI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
ETON
ETON
Revenue
$19.2M
$21.3M
Net Profit
$-3.8M
$1.5M
Gross Margin
61.6%
Operating Margin
-17.6%
11.6%
Net Margin
-19.7%
7.0%
Revenue YoY
35.8%
82.7%
Net Profit YoY
-34.6%
348.0%
EPS (diluted)
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
ETON
ETON
Q4 25
$19.2M
$21.3M
Q3 25
$18.4M
$22.5M
Q2 25
$19.0M
$18.9M
Q1 25
$15.1M
$17.3M
Q4 24
$14.1M
$11.6M
Q3 24
$12.6M
$10.3M
Q2 24
$12.4M
$9.1M
Q1 24
$12.0M
$8.0M
Net Profit
CURI
CURI
ETON
ETON
Q4 25
$-3.8M
$1.5M
Q3 25
$-3.7M
$-1.9M
Q2 25
$784.0K
$-2.6M
Q1 25
$319.0K
$-1.6M
Q4 24
$-2.8M
$-598.0K
Q3 24
$-3.1M
$627.0K
Q2 24
$-2.0M
$-3.0M
Q1 24
$-5.0M
$-811.0K
Gross Margin
CURI
CURI
ETON
ETON
Q4 25
61.6%
Q3 25
35.0%
Q2 25
63.0%
Q1 25
57.1%
Q4 24
55.6%
Q3 24
61.0%
Q2 24
62.0%
Q1 24
62.9%
Operating Margin
CURI
CURI
ETON
ETON
Q4 25
-17.6%
11.6%
Q3 25
-24.5%
-6.1%
Q2 25
2.5%
-7.8%
Q1 25
0.5%
-2.7%
Q4 24
-27.4%
5.4%
Q3 24
-25.8%
4.9%
Q2 24
-20.6%
-32.3%
Q1 24
-30.4%
-10.0%
Net Margin
CURI
CURI
ETON
ETON
Q4 25
-19.7%
7.0%
Q3 25
-20.4%
-8.6%
Q2 25
4.1%
-13.7%
Q1 25
2.1%
-9.1%
Q4 24
-19.9%
-5.1%
Q3 24
-24.3%
6.1%
Q2 24
-16.4%
-33.5%
Q1 24
-42.0%
-10.2%
EPS (diluted)
CURI
CURI
ETON
ETON
Q4 25
$-0.07
Q3 25
$-0.06
$-0.07
Q2 25
$0.01
Q1 25
$0.01
Q4 24
$-0.05
Q3 24
$-0.06
$0.02
Q2 24
$-0.04
$-0.12
Q1 24
$-0.09
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
ETON
ETON
Cash + ST InvestmentsLiquidity on hand
$27.3M
$25.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$26.2M
Total Assets
$75.7M
$92.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
ETON
ETON
Q4 25
$27.3M
$25.9M
Q3 25
$27.8M
$37.1M
Q2 25
$28.1M
$25.4M
Q1 25
$33.4M
$17.4M
Q4 24
$32.1M
$14.9M
Q3 24
$33.2M
$20.3M
Q2 24
$39.5M
$17.7M
Q1 24
$38.8M
$16.7M
Total Debt
CURI
CURI
ETON
ETON
Q4 25
Q3 25
Q2 25
Q1 25
$30.0M
Q4 24
$29.8M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CURI
CURI
ETON
ETON
Q4 25
$41.5M
$26.2M
Q3 25
$47.2M
$23.1M
Q2 25
$49.8M
$24.0M
Q1 25
$58.1M
$24.4M
Q4 24
$57.8M
$24.4M
Q3 24
$62.2M
$16.0M
Q2 24
$64.8M
$13.5M
Q1 24
$67.0M
$15.5M
Total Assets
CURI
CURI
ETON
ETON
Q4 25
$75.7M
$92.1M
Q3 25
$74.7M
$104.5M
Q2 25
$78.7M
$101.7M
Q1 25
$85.3M
$84.0M
Q4 24
$86.2M
$76.1M
Q3 24
$87.6M
$35.8M
Q2 24
$90.9M
$31.8M
Q1 24
$94.6M
$30.8M
Debt / Equity
CURI
CURI
ETON
ETON
Q4 25
Q3 25
Q2 25
Q1 25
1.23×
Q4 24
1.22×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
ETON
ETON
Operating Cash FlowLast quarter
$4.0M
$-11.6M
Free Cash FlowOCF − Capex
$3.9M
$-11.6M
FCF MarginFCF / Revenue
20.5%
-54.5%
Capex IntensityCapex / Revenue
0.1%
0.2%
Cash ConversionOCF / Net Profit
-7.79×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
ETON
ETON
Q4 25
$4.0M
$-11.6M
Q3 25
$4.4M
$12.0M
Q2 25
$2.8M
$8.0M
Q1 25
$1.9M
$2.1M
Q4 24
$3.0M
$-765.0K
Q3 24
$2.3M
$3.0M
Q2 24
$2.2M
$1.3M
Q1 24
$666.0K
$-2.5M
Free Cash Flow
CURI
CURI
ETON
ETON
Q4 25
$3.9M
$-11.6M
Q3 25
$11.7M
Q2 25
Q1 25
$1.8M
Q4 24
$-777.0K
Q3 24
Q2 24
Q1 24
$-2.5M
FCF Margin
CURI
CURI
ETON
ETON
Q4 25
20.5%
-54.5%
Q3 25
52.3%
Q2 25
Q1 25
12.2%
Q4 24
-6.7%
Q3 24
Q2 24
Q1 24
-31.2%
Capex Intensity
CURI
CURI
ETON
ETON
Q4 25
0.1%
0.2%
Q3 25
0.0%
1.3%
Q2 25
0.0%
0.0%
Q1 25
0.5%
0.0%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.0%
Q1 24
0.0%
0.2%
Cash Conversion
CURI
CURI
ETON
ETON
Q4 25
-7.79×
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
4.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons